After perfect storm, Dr Reddy's seeks recovery this fiscal Ruby Khatun Khatun3 Aug 2017 9:16 AM ISTNew Delhi: After facing a "perfect storm" of adverse developments, Dr Reddy's Laboratories expects better financial performance this fiscal with cost...
Key drug sales push Pfizer profit up 50 percent Ruby Khatun Khatun3 Aug 2017 9:15 AM ISTRising sales of key drugs, lower one-time charges and reduced manufacturing costs helped drive Pfizer's profit up 50 percent in the second quarter.The...
Indian destocking hits GSK consumer health care business Ruby Khatun Khatun30 July 2017 9:30 AM ISTGurugram: GlaxoSmithKline (GSK) Consumer Healthcare Limited declared its financial results for the fourth quarter and full year ended March 31,...
Glenmark Pharma records 47% jump in Q1 net at Rs 333 crore Ruby Khatun Khatun29 July 2017 9:25 AM ISTNew Delhi: Glenmark Pharmaceuticals reported a 47 per cent rise in consolidated net profit to Rs 333.38 crore for the first quarter ended June, mainly...
GSK Q1 net down 63% at Rs 26 crore on GST transition Ruby Khatun Khatun27 July 2017 9:20 AM ISTNew Delhi: GlaxoSmithKline Pharmaceuticals (GSK) on Tuesday reported 63.44 per cent decline in standalone net profit to Rs 26.42 crore for the first...
Sanofi India Q2 net dips 14 per cent at Rs 73 crore Ruby Khatun Khatun23 July 2017 9:53 AM ISTNew Delhi: Drug firm Sanofi India reported a 14.40 per cent dip in its net profit to Rs 73.7 crore for the second quarter ended June.The company had...
Alembic Pharmaceuticals Q1FY18 consolidated net profit declines 39 per cent yoy Ruby Khatun Khatun23 July 2017 9:50 AM ISTAlembic Pharmaceuticals consolidated revenue for the quarter came in at Rs. 648 crore, registering 12% yoy decline.This was driven by 21% yoy decrease...
Sanofi India's board declares an interim dividend of Rs 18 Ruby Khatun Khatun23 July 2017 9:49 AM ISTThe Board of Directors of the Sanofi India at its Meeting held on Wednesday has declared an Interim Dividend of Rs. 18 per equity share of Rs. 10 each...
Expect lower Q1 sales in India due to GST implementation: DRL Ruby Khatun Khatun4 July 2017 1:10 PM ISTNew Delhi: Drug major Dr Reddy's Laboratories (DRL) expects the first quarter of the ongoing fiscal to witness a temporary decline in sales in India...
Ipca Labs falls 15% as US regulator bans drug import Ruby Khatun Khatun17 Jun 2017 11:24 AM ISTNew Delhi: Ipca Laboratories shares tanked over 15 per cent on Friday as almost all drugs manufactured by the company at its facilities at Pithampur,...
Board of Kovai Medical Center and Hospital recommends final dividend Ruby Khatun Khatun15 Jun 2017 9:45 AM ISTThe board Of Kovai Medical Center and Hospital have recommended the final dividend of Rs 2.5 per equity Share.Kovai Medical Center and Hospital Ltd...
Aurobindo Pharma Q4 Net dips 4% to Rs 532 crore Ruby Khatun Khatun3 Jun 2017 9:30 AM ISTNew Delhi: Aurobindo Pharma posted a 4 per cent dip in consolidated net profit at Rs 532.22 crore for the fourth quarter ended March 2017.The company...
